Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model

Authors:

Abstract
No abstract available
Funding Information
  • National Center for Advancing Translational Sciences
  • National Cancer Institute

This publication has 25 references indexed in Scilit: